Adenoviral gene transfer of aspartoacylase ameliorates tonic convulsions of spontaneously epileptic rats

Neurochemistry International

Volumn 45, Issue 1, 2004, Pages 171-178

  Seki, Takahiro ^a   Matsubayashi, Hiroaki ^a   Amano, Taku ^a   Kitada, Kazuhiro ^b   Serikawa, Tadao ^c   Sasa, Masashi ^a,c   Sakai, Norio ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Adenoviral vector; Aspartoacylase; Gene transfer; Spontaneously epileptic rat; Tonic convulsions

Indexed keywords

ADENOVIRUS VECTOR; ASPARTOACYLASE; BETA GALACTOSIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; EPILEPSY; ESCHERICHIA COLI; FEMALE; GENE TRANSFER; HEART LEFT VENTRICLE; HELA CELL; HUMAN; HUMAN CELL; MALE; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TONIC SEIZURE; UTERINE CERVIX CARCINOMA;

ADENOVIRIDAE; AMIDOHYDROLASES; ANIMALS; EPILEPSY; EPILEPSY, TONIC-CLONIC; FEMALE; GENE THERAPY; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; INJECTIONS, INTRAVENTRICULAR; MALE; RATS;

ESCHERICHIA COLI;

EID: 1842787954     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2003.10.009     Document Type: Article

References (42)

1. Anderson W.F. Human gene therapy. Nature. 392:1998;25-30.
2. Bajocchi G., Feldman S.H., Crystal R.G., Mastrangeli A. Direct in vivo gene transfer to ependymal cells in the central nervous system using recombinant adenovirus vector. Nat. Genet. 3:1993;229-234.
3. Barkats M., Bilang-Bleuel A., Buc-Caron M.H., Castel-Barthe M.N., Corti O., Finiels F., Horellou P., Revah F., Sabate O., Mallet J. Adenovirus in the brain: recent advances of gene therapy for neurodegenerative diseases. Prog. Neurobiol. 55:1998;333-341.
4. Baslow M.H. A review of phylogenetic and metabolic relationships between the acylamino acids, N-acetyl-L-aspartic acid and N-acetyl-L-histidine, in the vertebrate nervous system. J. Neurochem. 68:1997;1335-1344.
5. Birken D.L., Oldendorf W.H. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci. Biobehav. Rev. 13:1989;23-31.
6. Blomer U., Naldini L., Kafri T., Trono D., Verma I.M., Gage F.H. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:1997;6641-6649.
7. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in au idiopathic epilepsy family. Nat. Genet. 18:1998;53-55.
8. Chen H.H., Mack L.M., Kelly R., Ontell M., Kochanek S., Clemens P.R. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. U.S.A. 94:1997;1645-1650.
9. Costantini L.C., Bakowska J.C., Breakefield X.O., Isacson O. Gene therapy in the CNS. Gene Ther. 7:2000;93-109.
10. Cua D.J., Hutchins B., LaFace D.M., Stohlman S.A., Coffman R.L. Central nervous system expression of IL-10 inhibits autoimmune encephaolmyelitis. J. Immunol. 166:2001;602-608.
11. Duke-Cohan J.S., Tang W., Schlossman S.F. Attractin: a cub-family protease involved in T cell-monocyte/macrophage interactions. Adv. Exp. Med. Biol. 477:2000;173-185.
12. Goldstein F.B. Amidohydrolases of brain enzymatic hydrolysis of N-acetyl-L-aspartate and other N-acyl-L-amino acids. J. Neurochem. 26:1976;45-49.
13. Hagan P., Barks J.D., Yabut M., Davidson B.L., Roessler B., Silverstein F.S. Adenovirus-mediated over-expression of interleukin-1 receptor antagonist reduces susceptibility to excitotoxic brain injury in perinatal rats. Neuroscience. 75:1996;1033-1045.
14. Hanaya R., Sasa M., Ishihara K., Akimitsu T., Iida K., Amano T., Serikawa T., Arita K., Kurisu K. Antiepileptic effects of 20-hydroxyecdysone on convulsive seizures in spontaneously epileptic rats. Japanese J. Pharmacol. 74:1997;331-335.
15. Jouvenceau A., Eunson L.H., Spauschus A., Ramesh V., Zuberi S.M., Kullmann D.M., Hanna M.G. Human epilepsy associated with dysfunction of the brain P/Q calcium channel. Lancet. 358:2001;801-807.
16. Kanegae Y., Makimura M., Saito I. A simple and efficient method for purification of infectious recombinant adenovirus. Japanese J. Med. Sci. Biol. 47:1994;157-166.
17. Kaul R., Casanova J., Johnson A.B., Tang P., Matalon R. Purification, characterization, and localization of aspartoacylase from bovine brain. J. Neurochem. 56:1991;129-135.
18. Kaul R., Gao G.P., Balamurugan K., Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nat. Genet. 5:1993;118-123.
19. Kitada K., Akimitsu T., Shigematsu Y., Kondo A., Maihara T., Yokoi N., Kuramoto T., Sasa M., Serikawa T. Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat. J. Neurochem. 74:2000;2512-2519.
20. Kuramoto T., Kitada K., Inui T., Sasaki Y., Ito K., Hase T., Kawaguchi S., Ogawa Y., Nakao K., Barsh G.S., Nagao M., Ushijima T., Serikawa T. Attractin/Mahogany/Zitter plays a critical role in myelination of the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 98:2001;559-564.
21. Mastakov M.Y., Baer K., Xu R., Fitzsimons H., During M.J. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol. Ther. 3:2001;225-232.
22. Matalon R., Michals K., Sebesta D., Deanching M., Gashkoff P., Casanova J. Aspartoacylase deficiency and N-acetylaspartic aciduria in patients with Canavan disease. Am. J. Med. Genet. 29:1988;463-471.
23. Miyake S., Makimura M., Kanegae Y., Harada S., Sato Y., Takamori K., Tokuda C., Saito I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. U.S.A. 93:1996;1320-1324.
24. Momiyama T., Ishihara K., Kimura K., Todo N., Fujita Y., Serikawa T., Sasa M. Long-term antiepileptic effects of chronic intake of CNK-602A, a thyrotropin-releasing hormone analogue, on spontaneously epileptic rats. Epilepsia. 37:1996;328-331.
25. Muzzin P., Cusin I., Charnay Y., Rohner-Jeanrenaud F. Single intracerebroventricular bolus injection of a recombinant adenovirus expressing leptin results in reduction of food intake and body weight in both lean and obese Zucker fa/fa rats. Regul. Pept. 92:2000;57-64.
26. Nakamura J., Tamura S., Kanda T., Ishii A., Ishihara K., Serikawa T., Yamada J., Sasa M. Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA/2 mice. Eur. J. Pharmacol. 254:1994;83-89.
27. Namboodiri M.A., Corigliano-Murphy A., Jiang G., Rollag M., Provencio I. Murine aspartoacylase: cloning. Mol. Brain Res. 77:2000;285-289.
28. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 108:1991;193-199.
29. Rehm S., Mehraein P., Anzil A.P., Deerberg F. A new rat mutant with defective overhairs and spongy degeneration of the central nervous system: clinical and pathologic studies. Lab. Anim. Sci. 32:1982;70-73.
30. Renming X., Ishihara K., Sasa M., Ujihara H., Momiyama T., Fujita Y., Todo N., Serikawa T., Yamada J., Takaori S. Antiepileptic effects of CNK-602A, a novel thyrotropin-releasing hormone analog, on absence-like and tonic seizures of spontaneously epileptic rats. Eur. J. Pharmacol. 223:1992;185-192.
31. Sasa M., Ohno Y., Ujihara H., Fujita Y., Yoshimura M., Takaori S., Serikawa T., Yamada J. Effects of antiepileptic drugs on absence-like and tonic seizures in the spontaneously epileptic rat, a double mutant rat. Epilepsia. 29:1988;505-513.
32. Seki T., Matsubayashi H., Amano T., Kitada K., Serikawa T., Sakai N., Sasa M. Adenoviral gene transfer of aspartoacylase into the tremor rat, a genetic model of epilepsy, as a trial of gene therapy for inherited epileptic disorder. Neurosci. Lett. 328:2002;249-252.
33. Serikawa T., Kogishi K., Yamada J., Ohno Y., Ujihara H., Fujita Y., Sasa M., Takaori S. Long-term effects of continual intake of phenobarbital on the spontaneously epileptic rat. Epilepsia. 31:1990;9-14.
34. Serikawa T., Ohno Y., Sasa M., Yamada J., Takaori S. A new model of petit mal epilepsy: spontaneous spike and wave discharges in tremor rats. Lab. Anim. 21:1987;68-71.
35. Serikawa T., Yamada J. Epileptic seizures in rats homozygous for two mutations. J. Hered. 77:1986;441-444.
36. Shi N., Pardridge W.M. Noninvasive gene targeting to the brain. Proc. Natl. Acad. Sci. U.S.A. 97:2000;7567-7572.
37. + channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction. Proc. Natl. Acad. Sci. U.S.A. 98:2001;6384-6389.
38. Traeger E.C., Rapin I. The clinical course of Canavan disease. Pediat. Neurol. 18:1998;207-212.
39. Ujihara H., Xie R.M., Sasa M., Ishihara K., Fujita Y., Yoshimura M., Kishimoto T., Serikawa T., Yamada J., Takaori S. Inhibition by thyrotropin-releasing hormone of epileptic seizures in spontaneously epileptic rats. Eur. J. Pharmacol. 196:1991;15-19.
40. Wood M.J.A., Charlton H.M., Wood K.J., Kajikawa K., Byrnes A.P. Immune responses to adenovirus vectors in the nervous system. Trends Neurosci. 19:1996;497-501.
41. Yamada J., Serikawa T., Ishiko J., Inui T., Takada H., Kawai Y., Okaniwa A. Rats with congential tremor and curled whiskers and hair. Exp. Anim. 34:1985;183-188.
42. Yamada K., Moriguchi A., Morishita R., Aoki M., Nakamura Y., Mikami H., Oshima T., Ninomiya M., Kaneda Y., Higaki J., Ogihara T. Efficient oligonucleotide delivery using the HVJ-liposome method in the central nervous system. Am. J. Physiol. 271:1996;R1212-R1220.